# Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

> clinical trial · VERIFIED · 2026-08-20

Status: RECRUITING · Sponsor: Jonsson Comprehensive Cancer Center · Condition: Anatomic Stage I Breast Cancer AJCC v8

- Company: Jonsson Comprehensive Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07191717

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.